Examining Vaccine Adjuvants and Industry Dynamics

This chapter critically explores the use of aluminum adjuvants in vaccines, highlighting discrepancies between labeled and actual contents, and raises concerns about their potential neurotoxic effects. The discussion extends to the financial motivations behind vaccine manufacturing, the complexities of the Vaccine Injury Compensation Fund, and conflicts of interest within regulatory bodies. It calls for improved transparency and safety evaluations akin to those required for food products, emphasizing the need for accountability in the vaccine industry.